Congressman Goodlatte and House Republican colleagues visited a drug-smuggling tunnel under the Mexican-US border to prove the utter futility of spending $25 billion to build a “big beautiful wall” to keep out drug smugglers.
Well, OK, that wasn’t really the purpose of the visit– Goodlatte, after all, is a strong advocate of the border wall boondoggle. But it might as well have been.
Meanwhile there’s no word from Goodlatte on some of those most responsible for the opioid addiction crisis in the US– the pharmaceutical industry, its lobbyists and their lackeys in Congress– who were called to account in a report on “60 Minutes” last Sunday by Joe Rannazzisi, who ran the Drug Enforcement Administration’s Office of Diversion Control, the division that regulates and investigates the pharmaceutical industry..
JOE RANNAZZISI: This is an industry that allowed millions and millions of drugs to go into bad pharmacies and doctors’ offices, that distributed them out to people who had no legitimate need for those drugs.
BILL WHITAKER: Who are these distributors?
JOE RANNAZZISI: The three largest distributors are Cardinal Health, McKesson, and AmerisourceBergen. They control probably 85 or 90 percent of the drugs going downstream.
Cardinal Health and McKesson were among the pharmaceutical industry donors to Goodlatte’s 2016 reelection campaign.